Supplementary Data 3 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer

<p>The synthetic androgen R1881 induces maximum proliferation in LNCaP AR/cs and LNCaP F877L cell lines at 0.1nM concentrations</p>